$ARE

Alexandria Real Estate (ARE) Q3 2026 Earnings Call Transcript

Alexandria Real Estate (ARE) reported Q3 2026 earnings with a net loss of $3.74 per share due to $637.9M in real estate impairment charges. FFO per share was $1.54, down from $2.22 YoY. Leasing volume reached 1.2M RSF, the highest in seven quarters. The company completed $2.6B in asset dispositions, exceeding guidance. Management expects temporary occupancy pressure in early 2027 and negative same-property NOI performance.

Original reporting
Published Oct 28, 2026, 3:54 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 28, 2026, 4:19 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Alexandria Real Estate (ARE) Q3 2026 Earnings Call Transcript — source image
Decision brief

The 30-second read

$AREBearishHigh
01

Why it matters

The earnings miss and large impairment charges are likely to trigger a sell‑off, but the capital raise and JV control may mitigate longer‑term risk.

02

Market read

First‑report earnings data for a mid‑cap REIT; material financial figures affect short‑term price action.

03

What to watch

Strong leasing volume and 11‑year weighted lease terms suggest underlying demand remains solid despite short‑term earnings miss.

Relevance 8/10Novelty 8/10Timing: post‑earnings release today

Background

Alexandria Real Estate Equities (ARE) reported Q3 2026 results with a net loss, significant impairments, and updated guidance.

Company-level read

Ticker impact

$AREBearishHigh confidence
Context

Q3 2026 earnings call disclosed a $3.74 per share net loss, $637.9M impairment and lowered FFO guidance, new capital raise and debt issuance.

Expected impact

downward pressure as investors price in the loss and impairment charges

Evidence & confidence

The disclosed loss and impairment are material and new; the REIT's leverage remains high, prompting short‑term sell pressure.

Market effects

Life‑science REIT sector may see broader valuation pressure from the impairment trend.

U.S. REIT market could experience slight pullback as investors reassess exposure to biotech‑linked properties.

Limited to U.S. REIT investors; no direct global macro effect.

Counterpoint

The impairment may be a one‑off cleanup, and the new capital raise could improve balance‑sheet flexibility, supporting a rebound.

Key entities

  • Alexandria Real Estate Equities, Inc.

    U.S. listed REIT focused on life‑science campuses.

Related articles

$AREMedAI 8/10

Alexandria Real Estate Equities Q3 Earnings Call Highlights

Alexandria Real Estate Equities (ARE) anticipates temporary occupancy pressure in early 2027 due to 1.4M sq ft of lease expirations, totaling $101M in expiring rent. Over 60% of 2027 lease rollovers are in discussions. The company expects occupancy growth in 2028 and negative same-property performance in 2027. ARE is pursuing advanced technology tenants and reduced its development pipeline by 50%. It completed $1.7B in capital activity, including asset sales and a $1B note offering.

$AREHighAI 8/10

Alexandria Real Estate Q3 earnings, revenue beat; narrows guidance range

Alexandria Real Estate Equities (ARE) reported Q3 earnings and revenue above estimates, with FFO per share at $1.54 and revenue at $671.2M. The company narrowed its 2026 adjusted FFO guidance to $6.38-$6.42. Occupancy fell to 88.1%, and expenses rose. ARE stock gained 0.5% in after-hours trading. The REIT plans asset sales and leasing to fund capital needs.